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Abstract
Background: Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. Studies have
correlated risk of CRC development with dietary habits and environmental conditions. Gene signatures for any
disease can identify the key biological processes, which is especially useful in studying cancer development. Such
processes can be used to evaluate potential drug targets. Though recognition of CRC gene-signatures across
populations is crucial to better understanding potential novel treatment options for CRC, it remains a challenging
task.
Results: We developed a topological and biological feature-based network approach for identifying the gene
signatures across populations. In this work, we propose a novel approach of using cliques to understand the
variability within population. Cliques are more conserved and co-expressed, therefore allowing identification and
comparison of cliques across a population which can help researchers study gene variations. Our study was based
on four publicly available expression datasets belonging to four different populations across the world. We
identified cliques of various sizes (0 to 7) across the four population networks. Cliques of size seven were further
analyzed across populations for their commonality and uniqueness. Forty-nine common cliques of size seven were
identified. These cliques were further analyzed based on their connectivity profiles. We found associations between
the cliques and their connectivity profiles across networks. With these clique connectivity profiles (CCPs), we were
able to identify the divergence among the populations, important biological processes (cell cycle, signal
transduction, and cell differentiation), and related gene pathways. Therefore the genes identified in these cliques
and their connectivity profiles can be defined as the gene-signatures across populations. In this work we
demonstrate the power and effectiveness of cliques to study CRC across populations.
Conclusions: We developed a new approach where cliques and their connectivity profiles helped elucidate the
variation and similarity in CRC gene profiles across four populations with unique dietary habits.
Background
Colon rectal cancer (CRC) is the third most commonly
diagnosed cancer worldwide. It is the second leading
cause of cancer death in the United States, and world-
wide, nearly 608,000 deaths are reported every year due
to CRC. The CRC incidence rate varies across the globe.
For example, low incidence rates for CRC have been
associated with Asian and African populations. Dietary
and environmental factors have also been known to
contribute to CRC patterns [1]. Therefore, we postulate
that there are some common as well as some unique
key gene signatures that can discriminate CRC across
populations.
Due to the advent of high through-put technologies, a
multitude of public domain expression datasets are now
available for CRC research. These datasets are generated
worldwide and deposited with the objective of identify-
ing key molecules that play an important role in differ-
ent stages of CRC. Gene-expression profiling and meta-
analysis have been extensively used to: a) understand
the mechanisms that drive a normal cell to become a
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cancer cell, b) understand different metastatic levels
[2-6], and c) identify biomarkers [7]. Differentially
expressed genes have been identified as biomarkers in
leukemia, B-cell lymphoma, breast and lung cancers
[8-11]. Gene signatures are a set of genes that might
play an important role in a given disease. Using gene
expression datasets, gene signatures were identified in
different cancers [12-14]. First attempts to identify gene
signatures from gene expression were done in breast
cancer [10]. Genes combine together and act as path-
ways to perform a biological function and genes in a
given pathway are co-expressed [15]. Large-scale efforts
are being made to identify the biomarkers associated
with specific pathways and biological function using
gene expression profiles [16-21]. A single pathway can
be deregulated by different mechanisms or combination
of genes. Also, a set of genes can target one or many
pathways. Gene signatures can help to identify these
patterns in pathways and also the relationships among
them [22]. First attempts for identifying gene signatures
were done for breast cancer [10] and have since been
used in various other cancers as well [12-14].
Network based approaches have been used to identify
subnetwork markers (gene signatures) that are more
reproducible than individual markers [23-25]. Functional
modules extracted from networks are groups of genes
with same functions [26]. The genes in the subnetworks
are co-expressed (high/low) and they share more inter-
actions among them, than with other genes in the larger
network [27,28]. These functional modules can be used
to identify both similar and unique biological character-
istics among different species datasets [29] and are also
considered to be subnetworks [30]. In protein-protein
interaction networks, these functional modules are pre-
sent as sub-graphs or tightly connected sub-graphs
[31,32] and can be analyzed with respect to their indivi-
dual characteristics using either Gene Ontology similari-
ties or Pathway significance [33-35]. Identification of
regulatory modules or gene subnetworks is important as
they play critical roles in biological processes [36] and
their associated pathways can provide potential targets
for drug intervention in cancers [37].
Though gene signatures can improve understanding of
a disease, identification of these signatures across popula-
tions is difficult, as gene expression is known to vary
between populations [38]. Even though modules have
been effectively used for the identification of gene signa-
tures, this approach is computationally complex because
the modules are open subnetworks [39], meaning that
within a disease network, a very large number of modules
will be identified [40]. Therefore, use of modules for
comparing gene signatures across populations is compu-
tationally an intractable problem. Though attempts have
recently been made to understand the difference in CRC
between African-Americans and European-Americans
[41] using a systems biology approach. However, not
much work has been done in the area of gene signature
identification across populations with respect to CRC.
Due to the complexity of gene signature identification,
we propose the use of cliques as an alternative to mod-
ules for the comparison of gene signatures across popu-
lations. Cliques are closed, fully-connected subnetworks.
The genes that are identified as part of these cliques are
functionally related and highly co-expressed [33]. Since
cliques are closed networks, they are both computation-
ally tractable and more conserved in the biological net-
works [42]. A clique consists of molecules that can be
associated with one or many pathways and these mole-
cules are related with their Gene Ontologies [43]. A
recent study reported the use of cliques in elucidating
the mechanisms involved in breast cancer [44].
In this paper we have attempted to understand CRC
gene signatures across four different populations: USA,
Germany (GER), China (CHN), and Saudi Arabia (SA).
The studies on each of these populations were con-
ducted separately, and the data was downloaded from
public repositories GEO http://www.ncbi.nlm.nih.gov/
geo. For the study model, we hypothesized that tumors
target biological modules that execute specific biological
processes [45]. Since cliques are fully connected con-
served subnetworks within biological networks, our
hypothesis is that they are conserved across populations
and can be understood as gene signatures. Therefore we
propose to understand these cliques in CRC across
populations. In this work we integrated the expression
data along with network topological features and biolo-
gical features. Cliques were then scored based on these
features. Our work identified the common and unique
cliques across populations that were important with
respect to CRC. To identify the important cliques we
analyzed the networks based on the following perspec-
tives: (i) identification of genes from individual datasets
based on p-value; (ii) construction of gene networks for
each population; (iii) annotation of nodes and edges of
networks with topological and biological features; (iv)
identification of cliques across networks; (v) comparison
of the cliques in all the networks based on their strength
and connectivity profiles; and, (vi) evaluation of the cli-
ques as gene signatures based on their biological signifi-
cance in CRC.
Results and discussion
jIn order to decipher the gene signatures and identify the
similarity-uniqueness among the four different populations
of CRC (USA, GER, CHN, SA), we developed a methodol-
ogy as described in Figure 1. Our methodology involved
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identifying genes in each dataset that satisfied the two
sample t-test, construction of the gene networks using
Human Protein Reference Database (HPRD) [46], obtain-
ing the gene expression profiles (up- and down-regulated
genes), identifying cliques in each dataset and comparing
them across the populations, and connecting the cliques
in each network to identify a Clique Connectivity Profile
(CCP) and comparing them across populations.
Data analysis
The gene expression in all the four datasets was first
normalized using the R-package RMA algorithm [47].
The two-sample t-test was used to identify the differen-
tially expressed genes in each dataset. The genes satisfy-
ing the t-test (p-value < 0.05 and q-value with FDR <
0.1) in each dataset were then used to construct the net-
works. Figure 2(a) shows the profile of gene expression
across the population dataset.
Network construction
To construct the gene network for each population, we
used only those genes that coded for proteins present in
the HPRD database [46]. The networks were compared
with respect to their node similarity. Table 1 shows the
node (i.e., gene) similarity across the four populations.
As shown in Table 1, a large number of genes were
common among USA, CHN and GER, but there were
fewer genes common with SA.
Analysis of population specific networks
To analyze these population-specific networks with
respect to their topological and biological features, these
networks were first compared with the HPRD network
for their interactions, degree, diameter, and average path
length. Table 2 shows the results of this comparison.
The average path-length is the overall ease with which
the genes in the network communicate with each other.
Figure 1 Overall methodology to identify the unique and common cliques in the population network. (i) Identify genes satisfying t-test
in each data set. (ii) Construct networks for each dataset and annotate each node and edge in the network with its respective topological and
biological features. (iii) Identify cliques of all sizes in each network and annotate each clique with its clique strength. Identify the maximum
common size and highest scored clique as the seed across networks. (iv) Using the seed, identify the clique connectivity profile across networks.
(v) Compare the clique connectivity profile (CCP) across network for commonality and uniqueness. (vi) Evaluate CCPs for their biological
processes and pathways across networks and identify gene signatures for CRC across populations.
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Though the degree and number of interactions differ for
GER, USA, and SA with HPRD, the diameter and the
average path lengths of these networks is in accordance
with HPRD. Therefore these networks have the ability
to generate functional complexes or modules and can
be analyzed with respect to their biological processes.
For further analysis of the networks, Pearson Correla-
tion Coefficients (PCC) were computed for each edge,
and correlations greater than 0.6 and less than -0.6 were
considered. This reduced the size and the complexity in
the networks.
Analysis of node strength based on topological
properties
The node strength for each node in the population specific
network was computed using the topological parameters -
namely, eccentricity, closeness and betweenness (see
method section, eqns. (i), (ii), (iii), and (iv)). The common
high scoring nodes identified in all the population were:
TP53, SRC, ESR1, SMAD3, GRB2, EP300, CREBBP,
Figure 2 (a) Gene expression profile for genes satisfying the t-test across populations. SA showed the highest number of up-regulated genes,
followed by GER, CHN, and then USA. (b) Clique distribution across population. USA had the highest number of cliques for all the sizes, while SA had the
lowest number of cliques. CHN and GER had nearly same number of cliques of all sizes. (c) Total number of unique cliques of respective sizes identified
across population. There was a large decrease in size 7 unique cliques identified in all the populations compared to numbers of cliques of other sizes. (d)
The number of common cliques identified across all populations was 49. The cliques identified in SA overlapped with all the other populations.
Table 1 Node similarity across population
Country







GER (7452) 6797 6815 6290
SA (7182) 6564 6587 –
CHN (7830) 7119 – –
Table 2 Comparison of population networks with HPRD
network
Network No. of interactions Degree diameter Av. Path length
HPRD 35706 7.79 4.22
CHI 27877 7.71 5.42
GER 25453 5.24 5.43
USA 28453 5.598 5.34
SA 24754 5.3 5.43
HPRD had the highest number of interactions. This illustrates that all four
population networks are sub-networks within HPRD
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EGFR, SMAD2, and CSN2KA1. Of these, the transcription
factors TP53, ESR1, SMAD3, and SMAD2 were identified
as important in CRC [48]. GRB2 overexpression has also
been identified in CRC [49] It was reported that binding
of GRB2 with GAB2 plays an important role in CRC [50].
GAB2 additionally interacts with BCR-ABL, activating
BCR-ABL-associated CRC significant pathways - specifi-
cally, PI3K-mTOR, RAS/RAF/MEK/ERK, and JAK-STAT
[51]. EP300 has also been identified to be involved in CRC
[52]. There were also a few unique top scoring nodes:
ATXN1 for GER and PRKCA, PRKACA and UBQLN4 for
SA. Not many references were available for UBQLN4 and
ATXN1 in CRC, although ATXN1 has been associated
with cancer pathways [53-55]. The topological analysis
revealed top scoring genes that are common (known) as
well as unique (not fully understood) with their signifi-
cance in CRC across the four populations.
Analysis of biological features for population specific
networks
The biological feature analysis provided the edge strength
for all the genes in all four population networks. The three
biological features considered for the analysis were: PCC,
Gene Ontology distance, and Pathway similarity score. The
PCC had already been computed during the network con-
struction process as described earlier (method section -
equation (v)). The number of edges satisfying the PCC in
each population network was: 15876 (USA), 12769 (CHN),
11664 (GER), and 9025 (SA). As it is known that, biological
processes are essentially a series of events accomplished by
one or more molecular functions. Each node in the net-
work was associated with its biological processes. Gene
Ontology distance was computed across an edge between
two nodes in the network (method section: equation (vi)).
The number of unique Gene Ontology biological processes
terms identified in each of the population networks were:
2806 (CHN), 2801 (GER), 2674 (SA), and 2791 (USA). The
following Gene Ontology biological processes were asso-
ciated with maximum number of genes in all networks:
GO: 0007165 (signal transduction), GO: 0006468 (protein
phosphorylation), GO: 0006955 (immune response), and
GO: 0055114 (oxidation-reduction process). Of these pro-
cesses, signal transduction pathways are currently used as
therapeutic targets in CRC [56], and immune response has
been associated with CRC progression [57]. Since these
biological processes are known to be important in CRC, we
concluded that GO biological process should be a key fea-
ture for computing the EdgeStrength (method section -
equation (vi)). Another key biological feature that we use
was the Pathway similarity score between two nodes. The
pathways were identified using the KEGG database [53,54],
and the number of unique pathways identified for the
respective populations were: 99 (CHN), 92 (USA), 54
(GER), and 87 (SA). There were a total of 105 unique
pathways across all the four populations: forty-nine path-
ways were common to all four countries, thirty-five were
common to three countries, seven were common to two
countries, and five were unique to one country. The CRC
pathways identified across all the countries were: Chemo-
kine signaling pathways, Wnt-signaling pathway, MAPK
signaling pathway, JAK-STAT pathway, Calcium-signaling
pathway, ErbB signaling pathway, and Pathways in cancer
[54,58,59]. The association of major CRC pathways with
the nodes thus justified the use of the pathway similarity
score as an essential feature for computing edge strength.
Each node in the network was annotated with its pathway,
and the pathway similarity score was computed across an
edge of two nodes in the network (method section - equa-
tion (vii)).
Through these various analyses, we obtained the topo-
logical and biological features for all four populations to
compute the NodeStrength and EdgeStrengths for their
respective genes in the networks.
Identification of cliques
Genes with similar expression patterns across various net-
works perform similar functions [27,28]. Both functional
modules and interacting modules have similar co-expressed
genes [60]. Based on this understanding, we designed an
algorithm that identified the cliques (described in method
section) in each population network. Figure 2(b) shows the
distribution of the number of identified cliques of different
sizes in each of the population-specific network. Figure 2
(c) shows the total number of unique cliques identified for
all four populations. The largest number of cliques (all sizes
included) was identified for USA and minimum for SA
respectively. In this analysis, we considered only cliques of
node size seven, as this size was found to be consistent
across all four population networks, while cliques of higher
sizes were not found across all the populations. For the spe-
cified clique size of seven, a total of 650 cliques were identi-
fied across the four populations. These cliques were then
further analyzed with respect to their distribution in the dif-
ferent populations. There were 49 cliques common to all
populations, while 20, 10, and 1 unique clique were identi-
fied in USA, GER, and CHN, respectively. Figure 2 (d)
shows the Venn diagram for the distribution of size seven
cliques across the four populations. The total number of
genes identified in these cliques within each population
network was: 126 (USA), 114 (CHN), 108 (GER), and 95
(SA). We identified 137 genes in total, with 57 of those
genes common among all cliques across the populations.
Analysis of cliques common across the populations
To understand the significance of the cliques across the
populations, we first analyzed all the cliques with
respect to their GO biological processes and pathway
associations. The numbers of GO biological processes
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associated with cliques for each population network
were: 247 (USA), 235 (GER), 222 (CHN), and 192 (SA),
247 (USA). GO terms with hyper-geometric p-values <
0.05 for each population were identified (method sec-
tion- equation (xi)); GO: 0007165, GO: 0006468 and
GO: 007049 were identified as the processes with the
smallest hyper-geometric p-values across all cliques in
all population networks. GO:0007165 was associated
with signaling pathways, which have been identified as
the targets for CRC [61]. GO: 007049 was associated
with cell division cycle. Previous studies found genes
involved in cell cycle, apoptosis, and invasion to play an
important role in CRC [62]. GO: 0006468 was asso-
ciated with protein phosphorylation. TGF-beta is a key
pathway involved in CRC, and progression of this path-
way is known to be dependent on protein phosphoryla-
tion [48,61,63]. The validation of these pathways with
respect to involvement in CRC supports that clique
nodes are involved in important GO biological pro-
cesses, and these enriched GO terms are key features by
which CRC can be evaluated across populations.
The identified cliques were further analyzed using GO
Term Finder [64], and DAVID level 3 [65]. Cliques identi-
fied as significant (p < 0.05) were further evaluated based
on literature. Table 3 shows the details of a few common
cliques identified in all the population networks and their
gene significance in CRC. It was also observed that some
of the genes in these common cliques have been widely
studied in terms of CRC, while others have relatively
sparse available literature.
The clique {EGFR, ESR1, GRB2, PIK3R1, PTPN6,
SHC1, SRC} in Table 3 was enriched in the following GO
biological processes: EGFR signaling pathway, cellular
response to growth, and signal transduction; most of the
genes in this clique have been identified as significant in
CRC. For example, targeted therapy using EGFR is cur-
rently available for CRC [66]. EGFR is a trans-membrane
tyrosine kinase receptor belonging to HER family of cell
surface receptor; it is triggered by ligands and leads to
the activation of many intracellular signal transduction
pathways (e.g., RAS, PI3K-AKT, STAT) [67] which are
known to effect the activation of many transcription fac-
tors involved in cellular response (differentiation, apopto-
sis, proliferation, and migration). ESR1 is used as a
epigenetic marker [64], while activation of GRB2/SOS,
leads to a cytoplasmic phosphorylation cascade involving
KRAS [68,69].
KRAS pathways are the targeted pathways in CRC
[70], PTPN6 mutation has not been identified specifi-
cally in CRC, but it has been found in other cancers,
including lymphoma and leukemia. Similarly, although
SHC1 has not been identified directly in CRC, it has
been identified in lung cancer [71].
The clique {BRCA1, CREBBP, EP300, ESR1, SMAD2,
SMAD3, TP53} was enriched with the following GO biolo-
gical processes: regulation of transcription, response to
lipid, and positive regulation of cellular metabolic process.
Again, these genes have all been studied in terms of CRC
or other cancers. CREBBP and EP300 have been identified
as prognostic markers for CRC [72], and EP300 is addi-
tionally been identified in lipid metabolism in CRC [65].
Some studies have identified BRCA1 [73], up-regulation of
CREBBP [52,72], mutation of EP300, loss of SMAD2 sig-
naling [74] in CRC. The TGF-Beta signaling pathway is
known to play an important role as tumor suppressor and
tumor promoters in CRC by activating the SMAD2/
Table 3 Common cliques across the four population datasets
Clique Enriched
GOTerms
Processes(p-value) Literature of CRC
EGFR, ESR1, GRB2, PTPN6, SHC1, SRC, PIK3R1 GO:0007173 EGFR signaling pathway (0.00253) ESR1 [69]
GO:0071363 Cellular response to growth GRB2 [49]
GO:0007105 Signal transduction (0.002) EEGFR [49]




GO:0033993 Response to lipid
(0.00266)
SMAD2 [48]




CSN2, CSN3, CSN4, CSN5, CSN6, CSN7, CSN8, TP53 GO:000338 Protein deneddylation (1.7E-18)
GO:0044267 Cellular protein metabolic process (0.00029)





GO:0006304 DNA modification (0.00192)
GO:0006402 mRNA catabolic process (0.00769)
GO TERM FINDER AND DAVID level 3 (biological processes) were considered for analysis.
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SMAD3 complex, which enters the nucleus to further reg-
ulate transcription [61,75]. Overexpression and mutation
of TP53 has also been associated with CRC [76-78].
The clique {CSN2, CSN3, CSN4, CSN5, CSN6,
CSN7A, CSN8, and TP53} is a part of signalosome of
CSN9, which acts as protein kinase. The enriched GO
biological processes were protein deneddylation and cel-
lular protein metabolism. CSN-mediated protein dened-
dylation has been identified in the literature to promote
Hedgehog-pathways, though it has not been reported
specifically in CRC [79]. CSN3 has been identified as
essential for cell proliferation in hepatocellular carci-
noma, while CSN5 is known to be a regulator of TP53
and MDM2; additionally, CSN6 is known to be impor-
tant for regulating DNA-damage-associated apoptosis
and tumor genesis, as well as enhancing p53-mediated
tumor suppression http://www.genedistiller.org. MDM2
has been identified as a probable therapeutic target for
CRC [62,80].
In the clique {DIS3, EXOSC2, EXOSC4, EXOSC5,
EXOSC7, EXOSC8, EXOSC9, and MPP6}, the enriched
GO biological processes identified were: DNA modifica-
tion, DNA deamination, and mRNA catabolic process. A
form of DNA modification that is used to identify many
cancers is DNA methylation in the promoter regions,
which causes silencing of many genes [81]. DIS3, which
has been identified in cancer genomes, stabilizes RNA
and its translation into proteins [82], while EXOSC4 is
involved in ribosome biogenesis and is highly up-regu-
lated in CRC [83]. Though not much has been reported
about the other genes in this clique with respect to
CRC, they have been identified in other cancers.
One of the unique cliques identified for USA was
{LSM1, LSM2, LSM3, LSM5, LSM6, LSM7, SMN1}. LSM1
is mapped on chromosome 8p11.2, which has been identi-
fied in both prostate cancer [78] and CRC. Although
SMN1 has not been identified in cancer directly, it has
been proposed to interact with BCL-2, which is associated
with CRC, and has a high prognostic value [84,85]. From
this analysis, it can be stated that common and unique cli-
ques identified across population networks are involved in
important biological processes in CRC. These cliques
include genes that are both well-studied and less-studied
in CRC, as well as those known to play a role in other can-
cers, indicating their importance in CRC networks and in
better understanding CRC across populations. This analy-
sis also demonstrates the importance of cliques in the
CRC disease and can be used to understand the four
population-specific networks.
Analysis of pathways associated with genes in cliques for
all populations
Cliques identified in the population-specific networks
were further analyzed using the KEGG database for
their pathway similarity score. Figure 3 shows the profile
of pathways associated with the maximum number of
genes in each network. This association varies across
populations. For example, Pathways in Cancer is asso-
ciated with the highest number of genes in all the popu-
lations - 26 (CHN), 26 (GER), 18 (USA), and 10 (SA);
many of the different pathways that belong to the
domain of Pathways in Cancer in the KEGG database
were discussed in the previous section. Though JAK-
STAT pathways were identified to be associated with
clique-genes in all the population, the level of associa-
tion, as defined by number of clique-genes identified,
was higher in GER (9) than in SA (3). Similar observa-
tions of varying levels of association were made for
many pathways, as can be seen in Figure 3.
Based on our analysis of the common cliques, unique
cliques, and pathways associated with the cliques for all
four populations, gene signatures for CRC can then be
developed from the genes identified in these cliques.
Specific gene signatures for each individual population
could also be developed using the unique cliques that
were identified in each population.
Analysis of CliqueStrength
The parameter CliqueStrength was computed for all cli-
ques in the population-specific networks based on both
topological and biological features (method section -
equation (ix)). Cliques associated with high CliqueS-
trength were considered important in these networks.
To assess the usefulness of the CliqueStrength para-
meter, we analyzed two top-scored cliques that were com-
mon or unique across the populations. Table 4 shows the
top scored cliques in each network, their associated biolo-
gical processes (GOTerm Finder, David level -3 terms),
and the genes associated with each process. Table 4 addi-
tionally shows that the CliqueStrength of a common clique
varies across population, as can be seen by comparing
scores for the first clique in USA (5.91) and CHN (5.85);
this is due to the fact that the parameter is a function of
topological and biological features, which, along with net-
work size, is variable across populations. The genes identi-
fied in the biological processes in the top scored cliques
were either transcription factors (SMAD2, JUN, SMAD3),
hub nodes, or those genes discussed in Table 5 that are
known to play an important role in CRC. The top scoring
clique identified in SA network was {MCM10, MCM2,
MCM3, MCM4, MCM6, MCM7, ORC2L}. Interaction of
highly expressed ORC2 and MCM6 is responsible for the
initiation of DNA replication [46]. Moreover, ORC2L is
not yet identified in CRC but is associated with breast can-
cer [43]. These results suggest that the top scored cliques
indeed are associated with genes of significance in CRC.
The high scoring cliques were further considered as a
seed to identify the clique connectivity profiles (CCP)
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for gene-signature identification. The overall connectiv-
ity using the top scoring clique can help to identify the
CRC gene signature profile for a specific population.
Discovering clique connectivity profile (CCP)
Cliques cannot carry out biological processes in isola-
tion, but rather, they interact with other cliques in order
Figure 3 Clique gene distribution in pathways across population. More clique-genes were associated with Pathways in Cancer in
population CHN, GER, USA than any other pathways for the same populations.
Table 4 Top scored cliques in each population network





Regulation of cell differentiation
EP300, SMAD2, JUN
CHN(5.85) GO:0045595
Regulation of cell differentiation
EP300, SMAD2, JUN
GO:0048522
Positive regulation of cellular process
EP300, SMAD2, SMAD3,
SMAD4, SP1, ESR1, JUN











Regulation of cell morphogenesis
EP300, SMAD2
PTPN11, CBL, SRC, PRKCA, SHC1, PTPN6, EGFR SA(3.75) GO:0007173
Epidermal growth factor
Receptor signaling
EGFR, PRKCA, SHC, CBL, SRC, SHC1,
PTPN11
GO:0071363
Response to growth factor stimulus
PRKCA, CBL, SHC







G1/S transition of mitotic cell cycle
ORC2L, MCM6
CliqueStrength of each clique was represented in brackets with respect to the population in which it was identified
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to perform a biological process. These interactions can
also help to identify the interacting pathways between
cliques. Identifying a clique’s connectivity profile (CCP)
is important for better understanding the biological pro-
cesses and pathways. To decipher how these cliques
interacted in the network, we analyzed them based on
their connectivity profile. In our algorithm, we considered
the connectivity of cliques based on two parameters: (i)
identification of common (links) genes, and (ii) CliqueS-
trength (based on topological and biological features-
equation (viii)). The initial condition of the CCP algorithm
was the identification of common genes across cliques.
For this analysis, the connectivity between two cliques was
computed based on the following two conditions: (a) max-
imum number of common genes across cliques and High-
est CliqueStrength (MaxCliques), and (b) minimum
number of common genes across cliques and Highest Cli-
queStrength (MinCliques), (nn < = 4, where nn = number
of common genes across cliques).
Analysis based on MaxCliques condition
The clique with maximum CliqueStrength was selected as
a seed, and the CCP was determined based on maximum
common nodes and highest CliqueStrength until no new
cliques could be added. For each iteration, the CliqueCon-
nectivityScore was computed as described in the algorithm
(Method section equation (x)). Figure 4 depicts the con-
nectivity profile for one of the top common scoring cliques
identified in USA, GER and CHN. These populations had
cliques that were common and unique to all three connec-
tivity profiles. Although the three CCPs shown in Figure 4
originated from the same seed, their connectivity profiles
diverged at cliques #17 {EP300, ESR1, SMAD4, SMAD3,
CBP, AR, CTNNB1}, #39 {BRCA1, EP300, ESR1, SMAD3,
SMAD, TP53, SP1}, and #GC1 {EGFR, GRB2, PIK3R1,
PTPN6, SHC, SRC, ESR1}. Clique#17 was the first diver-
gent point where the profiles differed for CHN when com-
pared to USA and GER. Expression of AR, which was
included in Clique#17, has been associated with BRCA1
mutations in breast cancer [86]. Clique#39 includes
BRCA1, whose mutations are associated with early-onset
of colorectal cancer [48].
Transcription factors (SMAD2, SMAD3, P53, SMAD4,
SP1, JUN) significant in CRC [48] were also identified
both as hub nodes in our analysis and in these connectiv-
ity profiles. Using GOTerm finder and David-level 3, the
biological processes for these CCPs were identified, and
pathways associated with these CCPs were obtained from
the KEGG database. Table 5 shows the enrichment with
respect to GO biological processes and pathway analysis
for these clique connectivity profiles.
The biological processes enriched in all three clique
connectivity profiles (CCP) included Cellular process,
and Cell differentiation. These were analyzed in earlier
section of this paper and proved to be significant in CRC.
The total numbers of pathways identified for genes pre-
sent in the CCPs for each population were: 6 (USA), 22
(GER), and 25 (CHN). All pathways identified in USA
and GER were also present in CHN. In USA, the pathway
with lowest E-value was the Wnt signaling pathway; how-
ever, for GER, the ErbB signaling pathway was the lowest.
Wnt signaling was identified in CHN along with the
MAPK and Chemokine signaling pathways. These path-
ways are all known to be associated with biological pro-
cesses in CRC [59,87-89].
Figure 5 depicts the CCPs constructed using MaxCli-
ques for top scored cliques common to USA and SA.
From this figure it can be observed that the CCP diverges
at the seed itself, indicating divergence in gene regulation
between USA and SA. The biological processes associated
Table 5 Analysis of clique connectivity profile MaxCliques
Population Result of GO TERMFINDER & DAVID level 3 Pathways (p-value)
USA Positive regulation of cellular processes (1.2E-7) Wnt Signaling (4.3E-7)
Colorectal Cancer (2.3E-6)
Regulation of cell proliferation (3.3E-5) TGF-beta signaling (2.7E-6)
Cell cycle (1.2E-5)
Signal transduction (2.05E-5)
Pathways in Cancer (1.7 E-3)
Hunting disease (2.3E-2)
GER Cell morphogenesis (3.1E-6) ErbB signaling pathway (1.5 E-7)
Cellular response to chemical stimulus (4.4E-06) Focal adhesion (1.1E-6)
GnRH signaling pathway (3.2E-3)
Positive regulation of cellular process (1.1E-11) JAK-STAT(1.1E-3)
Neurotrophin signaling pathway (2.8E-5)
CHN Positive regulation of cellular process (7.3E-11) Wnt Signaling (5.1E-5)
Regulation of cell differentiation(1.3E-4) B cell receptor signaling pathway(2E-2)
Regulation of growth(5.8E-04) T cell receptor signaling pathway (3.9E-2)
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with USA CCP were: positive regulation of cellular pro-
cesses (1.2E-7), regulation of cell differentiation (1.1E-4),
regulation of DNA binding (0.0062), and regulation of cell
growth (1.3E-3) associated with CRC pathways. The biolo-
gical processes associated with SA CCP were: regulation of
metabolic process (4.8E-06), regulation of cell differentia-
tion (6.9E-4), regulation of immune response (9.83E-09),
and their associated pathways were: TGF-beta signaling,
Wnt signaling, NOD-like receptor pathways, Toll-like sig-
naling pathways, and MyD88 induced toll-like receptor
pathways. Most of the biological processes identified
across the CCP were common to both and are known to
be associated with CRC, but the pathways associated with
these processes were not overlapping. In the SA CCP, toll-
like signaling pathway is identified. Toll-like receptor path-
ways play a key role in all the immune responses in CRC
and are identified for cancer therapy [90]. While common
cliques and pathways were identified for the populations
of interest, subsequent analysis was also able to determine
points of divergence within the connectivity profiles across
all four populations.
This analysis depicts the importance of cliques and their
connectivity profiles with respect to the important biologi-
cal processes, and pathways and it helps to demonstrate
the divergence of them across the four populations.
Analysis based on MinCliques condition
Using the same seed as given in Figure 4, we found the
CCPs for MinCliques as shown in Figure 6. The USA CCPs
identifed a new clique that contains the EGFR gene, whereas
for GER and CHN, the CCP identified the same divergent
clique as shown in Figure 4 {EGFR, GRB2, PIK3R1, PTPN6,
SHC, SRC, ESR1}. The CCP then diverged for GER and
CHN. For CHN, the new connected clique contained the
genes {ZAP70, VAV1, FYN, and CRK} while the GER clique
had {STAT1, PTPN11, EGFR, JAK2, STAT5B, STAT5A,
and STAT3}. ZAP 70 and VAV1 are known to be over-
expressed in CRC [91], and STAT1, JAK2, and others are
related to the JAK-STAT pathways associated with CRC.
Figure 6 depicts the advantages and disadvantages of using a
threshold for overlapping nodes to identify CCP - the alter-
ing the number of overlapping nodes.
When all clique sizes were considered for the MaxCli-
ques algorithm, our study identified cliques with TAF1,
TAF10, JUN, and FOS in all the populations. TAF1 is a
regulator of apoptosis in cancer [92] and has been identi-
fied to be up-regulated in NCI-60 cell lines [93]. KRAS,
which was present in a size three clique, was identified in
USA, SA, and China populations. KRAS clique had its
CCPs connected with the clique of BCL2 (size five-six).
KRAS pathways are known to be associated with CRC
Figure 4 Clique Connectivity Profile (MaxCliques). (Green-USA, Light blue-GER, Dark Blue-CHN). The figure depicts the clique connectivity
profile for each of the populations. The seed was the same for all the populations, but the iteration considered maximum overlapping clique
nodes and highest strength, resulting in overlapping nodes. The CCP diverges at three cliques, where the profile changes. The diverging cliques
identified the genes that are both significant in CRC.
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[54]. The clique {MCM10, MCM2, MCM3, MCM4,
MCM6, MCM7, ORC2L} identified in Table 4 was asso-
ciated with cliques of CDKN1A (size four, five) in all the
populations and down-regulation of CDKN1A plays a
role in CRC [94]. The clique {DIS3, EXOSC2, EXOSC4,
EXOSC5, EXOSC7, EXOSC8, EXOSC9, MPP6} identified
in Table 3 does not have any CCP with any other size cli-
ques in any population networks.
Figure 5 Clique Connectivity Profile MaxCliques. (Green USA, Yellow SA): This figure depicts the seed common to USA/SA. The iteration
considered the identification of next clique by evaluating the maximum overlap and highest strength. It can be seen that the profile diverges at
the seed itself. The genes identified in CCPs of both USA and SA are significant in CRC. This figure depicts the variability in the expression of
genes across the population.
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Genes present in cliques can form signatures for CRC
specific to population. The CCP algorithm, if preceded
with either MaxCliques or MinCliques, will still identify
the important genes associated with CRC. Analysis of cli-
ques of all sizes can identify the divergence in CCPs across
population. As the definition of cliques is more stringent
than that of modules, networks have fewer cliques than
modules, allowing for more manageable analysis. Our ana-
lysis showed that CCPs can identify the commonality and
divergence across populations. The ability of both cliques
and CCPs to identify commonalities and divergences
allows for them to be considered as gene signatures for
CRC and can be evaluated further in the laboratory.
Conclusions
In this paper we developed a methodology for identifica-
tion of commonalities and variations in CRC across
populations by evaluating cliques and their connectivity
Figure 6 Clique Connectivity Profile for MinCliques (Green-USA, Light blue-GER, Dark Blue-CHN). This figure depicts the CCP for USA,
GER, and CHN that was identified using a common seed (same as in Figure IV). The algorithm considered minimum overlapping nodes with
highest CliqueStrength. From this figure, we can see the CCP diverges at the seed itself for the three populations. In SA, we identified two
cliques that have the same number of overlapping nodes with the seed and same clique strength. Therefore we see two gene signature profiles
of SA, both of which end at the same clique.
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profiles. In this study, we considered four distinct popu-
lations across the world. We used both topological and
biological features - specifically co-expression, GO dis-
tances for biological process, and pathway similarity
scores - in our network analysis. We additionally intro-
duced the concept of using cliques to capture gene sig-
natures for CRC across populations. The methodology
developed for joining cliques is powerful for finding the
commonalities and divergences among populations with
respect to their gene signatures. Using the CCP, we
were able to capture important network components,
including biological processes, pathways, and genes, and
use these to elucidate the gene signature of CRC. The
advantage of using cliques as opposed to functional
modules is that although there are fewer cliques in a
network, they are still able to capture the key gene sig-
natures of a disease. Though the current study only
applied the use of clique analysis to small datasets, we
plan to validate the procedure in larger datasets. We
additionally plan to make our CCP algorithm more
stringent with respect to overlapping nodes. As our
methodology is scalable with respect to annotation, dif-
ferent features such as static and dynamic profiles, lit-
erature score, and phenotypes can give in-depth
stratification of CRC across populations. Comparison of
all cliques (through their CCP) as gene signatures across
populations may ultimately aid the advancement of per-
sonalized medicine and the identification of efficient
drug targets.
Methods
In order to decipher the gene signatures and identify the
similarity/uniqueness among the four different popula-
tions of CRC, the following methodology, as illustrated
in Figure 1, was adopted.
Datasets
Four independent microarray studies available in the pub-
lic domain repository GEO http://www.ncbi.nih.gov/geo
were considered for this study. These studies were per-
formed on the GPL 570 platform. The datasets from four
different food habitats were considered - CHN, GER, SA
and USA. These populations are quite distinct with
respect to each other as there is less commonality in their
diet and environmental conditions. The statistics for these
different datasets are: (i) GER (GSE4183): 23 disease and 8
healthy control samples; (ii) SA (GSE23878): 35 disease
and 24 healthy control samples; (iii) USA (GSE 13471): 4
disease and 4 healthy control samples; and, (iv) CHN
(GSE22242): 1 disease and 1 healthy control sample. Raw
data in each case was processed using the RMA algorithm
in R Bio conductor http://www.r-project.org[47]. The nor-
malized datasets were then analyzed by two-sample t-test.
The genes satisfying the t-test (p-value < 0.05 and q-value
with FDR < 0.1) were further considered for differential
expression analysis across the populations.
Construction of the interaction network
For the above genes the population specific networks,
were constructed using the protein-protein interactions
obtained from the HPRD database [46].
Analysis of population specific networks
Networks were first analyzed individually based on their
topological and biological features. Each node in the
network was first annotated for its topological proper-
ties, with the edges providing the biological significance.
Node strength based on topological properties
Using the statistical computing tool R, each node in the
network was scored for its Degree, Eccentricity, Close-
ness, and Betweenness properties. Degree was defined by
the number of connections a given node had with other
nodes in the network. Eccentricity of a node was defined
by the ease with which it could be accessed by all the
other nodes in the network. Eccentricity of a node v was
calculated by computing the shortest path between the
node v and all other nodes in the network as,
Eccentricity (Eecc (v)) =
1
max {dist (v,w) : w ∈ V} (i)
Where w represents the number of nodes in set V of
nodes and has the shortest distance to node v.
Closeness of a node v is the average of the shortest
path between the node v and all other nodes in the net-
work and was given by,




Betweenness of a node v is the inverse of the ratio of
total number of shortest paths from node s to node t
given by sst to the number of total paths passing
through node v (sst (v)). This was computed as,






Each of the above features was computed and normal-








Edge strength based on biological properties
The edge strength was defined as the weight assigned to
an edge connecting the two nodes (vi, vj) in the network.
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Edge strength was computed based on three biological
features: PCC, Gene ontology distance, and pathway
similarity score. PCC was used as a similarity measure
between the two nodes as it identified the co-expressed
genes, which encode interacting proteins and help in
understanding cellular patterns [95], in the network.
The PCC was calculated for nodes (vi, vj) as,
PearsonCorrvivj =
∑n
k=1(vik − vimean)(vjk − vjmean)√∑n
k=1 (vik − vimean)2(vjk − vjmean)2
(v)
Where vimean, vjmean of the sample is means for the
genes i and j, and n is number of samples.
The genes in the network were annotated based on
GO biological process and evaluated for their similarity.















GO (Gi) ∪ GO (Gj)) + # (GO(Gi) ∩ GO(Gj) (vi)
Where, Δ is the symmetric set difference, and GO(Gi)
is the number of GO annotations for vi. Similarly, we
computed GO(Gi)) for vj. If the GO distance between
(vi, vj) was less than 1.0, they were considered interact-
ing. The interacting nodes are considered for construct-
ing the network.
The Pathway similarity score was computed using
pathways in KEGG database [53,54]. Each gene was
annotated with its associated pathway, and the gene-
pathway similarity score was computed as follows:
Let (vi, vj) represent the two nodes in the network. Let
PN represent a set of pathways where gene vi is present,
and PM represent the set of pathways where gene vj is
present. Pcommon then equals the number of common
pathways identified in PN and PM, and Unique equals
the unique number of pathways present in PN and PM.










The three biological features were further normalized,
and each interaction in the network was scored based
on the average score for each of the features and given
as,
EdgeStrengthvivj =
PearsonCorrNorm + GeneOntologyDistanceNorm + PathwaySimilarityScoreNorm
3 (viii)
Identification of cliques
Cliques are fully connected, conserved, and co-expressed
in the networks [33,42]. We developed a graph-based
approach to identify cliques in the networks with the
purpose of understanding them as gene signatures
across population. A clique was defined as a fully con-
nected graph, as shown in Figure 1 (a). Let G = (V, E)
be any arbitrary undirected graph with V = {1,2,3 ... N}
as its vertices, and E = {(1, 2), (1, 3), ..., (1, N)}, the set
of corresponding edges. A clique C is a sub-graph of V
such that C Î V and every vertex of C in the sub-graph
is connected to all the other C - 1 vertcies. Each popula-
tion network was then analyzed for cliques of various
sizes, ranging from 3 to M nodes. For our analysis, M =
7. The strength of a clique was defined based on the
associated node strength (eqn. (iv)) and edge strengths






NodeStrength + EdgeStrength (ix)
We used the greedy algorithm to first identify three-
node cliques in the networks as a seed. The seed was
then used for identifying cliques of higher sizes, ranging
from four to seven nodes.
Clique connectivity profile algorithm (CCP)
To understand the profile of the cliques across popula-
tion, we developed an algorithm to discover the connec-
tivity profile of the cliques based on the number of
common nodes. Our hypothesis for this connectivity
rule was that cliques with common nodes may have
similar pathways and Gene Ontology biological pro-
cesses. Each clique may traverse the network by taking
different paths. Identification of the clique connection
profile (CCP) was important to understanding the gene
signature of CRC as the interacting genes in these cli-
ques might be important for a function in a given biolo-
gical process. The CCP algorithm annotated each clique
with its total CliqueStrength (equation (ix)), and then
identified its closest clique connection based on the
number of common nodes and CliqueStrength. This
CCP algorithm iteratively progressed until no new clique
could be added to the path. The clique connectivity





The CCP algorithm first identified the clique (for simi-
lar size) with highest strength common to all the popula-
tion. Using this as a seed, the algorithm proceeded
ultimately produced a network of cliques that provided
the gene signatures that are present across the popula-
tions for CRC. The smaller size cliques were added to
this network of cliques. These CCPs could then be used
to understand the commonality and uniqueness as gene-
signatures in CRC across populations.
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Statistical evaluation of cliques using gene enrichment
analysis
Hyper-geometric distribution based on p-value was used
for identifying the significance of GOTerms in the net-















where, significance of a given GOTerm x, gg genes in
the n genes of cliques, and that is associated to g genes
from G genes in the population network. GO Terms
with p-values less than 0.05 were further used for ana-
lyzing the biological significance of the cliques.
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